Laboratory of Protein Phosphorylation & Proteomics, Dept. of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium; Leuven Cancer Institute (LKI), Leuven, Belgium; Leuven Brain Institute (LBI), Leuven, Belgium.
Laboratory of Protein Phosphorylation & Proteomics, Dept. of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium; Leuven Cancer Institute (LKI), Leuven, Belgium; Leuven Brain Institute (LBI), Leuven, Belgium.
Biochim Biophys Acta Mol Cell Res. 2019 Jan;1866(1):31-50. doi: 10.1016/j.bbamcr.2018.07.010. Epub 2018 Jul 18.
Protein Phosphatase 2A (PP2A) encompasses a large family of Ser/Thr phosphatases, consisting of a catalytic C subunit and a structural A subunit that are, in most cases, further bound to a regulatory B-type subunit. The B-type subunits determine function and regulation of PP2A trimers, but despite their importance in PP2A biology, their roles in controlling dephosphorylation of a given substrate in a given cell or tissue remain poorly defined, particularly in the context of a complete organism. Besides twenty PP2A subunit encoding genes, some of which are tissue-specifically expressed, five additional genes encode major regulators of active PP2A trimer assembly, and at least seven genes encode cellular PP2A inhibitors, further adding to the complexity of the mammalian PP2A system. In this review, we summarize current knowledge on physiologic functions of PP2A in germ cell maturation, embryonic development, metabolic regulation, tumor suppression, and homeostasis of adult brain, heart, liver, immune system, lung, intestine, kidney, skin, bone and eye, all retrieved from in vivo studies using PP2A transgenic, knockout or knockin mice. Data from 63 mouse models, generated between 1998 and now, reveal the essentiality of PP2A in vivo, and shed light on tissue-specific functions of particular PP2A subunits on the one hand, and functional redundancies on the other hand. In future, it remains of utmost importance to further characterize the existing models, as well as to generate novel models, with the aim of deepening our insights in PP2A (patho)physiology and, particularly, in the therapeutic potential of PP2A targeting in human disease.
蛋白磷酸酶 2A(PP2A)包含一个庞大的丝氨酸/苏氨酸磷酸酶家族,由一个催化 C 亚基和一个结构 A 亚基组成,在大多数情况下,A 亚基进一步与调节性 B 型亚基结合。B 型亚基决定 PP2A 三聚体的功能和调节,但尽管它们在 PP2A 生物学中很重要,但它们在控制特定细胞或组织中特定底物的去磷酸化作用方面的作用仍未得到明确界定,特别是在完整生物体的背景下。除了二十个 PP2A 亚基编码基因,其中一些是组织特异性表达的,还有五个额外的基因编码活性 PP2A 三聚体组装的主要调节剂,至少有七个基因编码细胞 PP2A 抑制剂,这进一步增加了哺乳动物 PP2A 系统的复杂性。在这篇综述中,我们总结了目前关于 PP2A 在生殖细胞成熟、胚胎发育、代谢调节、肿瘤抑制和成年大脑、心脏、肝脏、免疫系统、肺、肠道、肾脏、皮肤、骨骼和眼睛的稳态中的生理功能的知识,这些知识都是从使用 PP2A 转基因、敲除或敲入小鼠的体内研究中获得的。从 1998 年至今生成的 63 个小鼠模型的数据揭示了 PP2A 在体内的重要性,并揭示了一方面特定 PP2A 亚基的组织特异性功能,另一方面是功能冗余。在未来,进一步表征现有的模型以及生成新的模型仍然至关重要,目的是加深我们对 PP2A(病理)生理学的了解,特别是对靶向 PP2A 在人类疾病中的治疗潜力的了解。